188 related articles for article (PubMed ID: 11872372)
1. Hexosamines as mediators of nutrient sensing and regulation in diabetes.
McClain DA
J Diabetes Complications; 2002; 16(1):72-80. PubMed ID: 11872372
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance.
Cooksey RC; McClain DA
Ann N Y Acad Sci; 2002 Jun; 967():102-11. PubMed ID: 12079840
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mice with increased hexosamine flux specifically targeted to beta-cells exhibit hyperinsulinemia and peripheral insulin resistance.
Tang J; Neidigh JL; Cooksey RC; McClain DA
Diabetes; 2000 Sep; 49(9):1492-9. PubMed ID: 10969833
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance.
Veerababu G; Tang J; Hoffman RT; Daniels MC; Hebert LF; Crook ED; Cooksey RC; McClain DA
Diabetes; 2000 Dec; 49(12):2070-8. PubMed ID: 11118009
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione.
Cooksey RC; Hebert LF; Zhu JH; Wofford P; Garvey WT; McClain DA
Endocrinology; 1999 Mar; 140(3):1151-7. PubMed ID: 10067838
[TBL] [Abstract][Full Text] [Related]
6. Hexosamines and insulin resistance.
McClain DA; Crook ED
Diabetes; 1996 Aug; 45(8):1003-9. PubMed ID: 8690144
[TBL] [Abstract][Full Text] [Related]
7. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance.
Hazel M; Cooksey RC; Jones D; Parker G; Neidigh JL; Witherbee B; Gulve EA; McClain DA
Endocrinology; 2004 May; 145(5):2118-28. PubMed ID: 14684615
[TBL] [Abstract][Full Text] [Related]
8. Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway.
Cooksey RC; McClain DA
Amino Acids; 2011 Mar; 40(3):841-6. PubMed ID: 20658157
[TBL] [Abstract][Full Text] [Related]
9. Adipocytes with increased hexosamine flux exhibit insulin resistance, increased glucose uptake, and increased synthesis and storage of lipid.
McClain DA; Hazel M; Parker G; Cooksey RC
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E973-9. PubMed ID: 15613679
[TBL] [Abstract][Full Text] [Related]
10. Hexosamines stimulate leptin production in transgenic mice.
McClain DA; Alexander T; Cooksey RC; Considine RV
Endocrinology; 2000 Jun; 141(6):1999-2002. PubMed ID: 10830282
[TBL] [Abstract][Full Text] [Related]
11. Role of hexosamines in insulin resistance and nutrient sensing in human adipose and muscle tissue.
Pouwels MJ; Tack CJ; Span PN; Olthaar AJ; Sweep CG; Huvers FC; Lutterman JA; Hermus AR
J Clin Endocrinol Metab; 2004 Oct; 89(10):5132-7. PubMed ID: 15472217
[TBL] [Abstract][Full Text] [Related]
12. Regulation of glycogen synthase and protein phosphatase-1 by hexosamines.
Crook ED; McClain DA
Diabetes; 1996 Mar; 45(3):322-7. PubMed ID: 8593937
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.
Hebert LF; Daniels MC; Zhou J; Crook ED; Turner RL; Simmons ST; Neidigh JL; Zhu JS; Baron AD; McClain DA
J Clin Invest; 1996 Aug; 98(4):930-6. PubMed ID: 8770864
[TBL] [Abstract][Full Text] [Related]
14. Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG
Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E1-E8. PubMed ID: 16339923
[TBL] [Abstract][Full Text] [Related]
15. Glutamine: fructose-6-phosphate amidotransferase activity and gene expression are regulated in a tissue-specific fashion in pregnant rats.
Yki-Järvinen H; Nyman T; Rissanen E; Leino M; Hämäläinen S; Virkamäki A; Hauguel-de Mouzon S
Life Sci; 1999; 65(2):215-23. PubMed ID: 10416827
[TBL] [Abstract][Full Text] [Related]
16. Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver.
Robinson KA; Weinstein ML; Lindenmayer GE; Buse MG
Diabetes; 1995 Dec; 44(12):1438-46. PubMed ID: 7589852
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of glutamine:fructose-6-phosphate amidotransferase in rat-1 fibroblasts enhances glucose-mediated glycogen accumulation via suppression of glycogen phosphorylase activity.
Crook ED; Crenshaw G; Veerababu G; Singh LP
Endocrinology; 2000 Jun; 141(6):1962-70. PubMed ID: 10830278
[TBL] [Abstract][Full Text] [Related]
18. Effects of overexpression of glutamine:fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells.
Chen H; Ing BL; Robinson KA; Feagin AC; Buse MG; Quon MJ
Mol Cell Endocrinol; 1997 Nov; 135(1):67-77. PubMed ID: 9453242
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glutamine:fructose-6-phosphate amidotransferase activity by high glucose and transforming growth factor beta in rat mesangial cells.
Crook ED; Simmons ST; Daniels M; Singh LP
J Investig Med; 2000 Nov; 48(6):427-34. PubMed ID: 11094865
[TBL] [Abstract][Full Text] [Related]
20. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress.
Kaneto H; Xu G; Song KH; Suzuma K; Bonner-Weir S; Sharma A; Weir GC
J Biol Chem; 2001 Aug; 276(33):31099-104. PubMed ID: 11390407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
